Wu B - Search Results

1

Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial.

Kim TW, Bedard PL, LoRusso P, Gordon MS, Bendell J, Oh DY, Ahn MJ, Garralda E, D'Angelo SP, Desai J, Hodi FS, Wainberg Z, Delord JP, Cassier PA, Cervantes A, Gil-Martin M, Wu B, Patil NS, Jin Y, Hoang T, Mendus D, Wen X, Meng R, Cho BC. Kim TW, et al. Among authors: wu b. JAMA Oncol. 2023 Nov 1;9(11):1574-1582. doi: 10.1001/jamaoncol.2023.3867. JAMA Oncol. 2023. PMID: 37768658 Free PMC article.

2

Multistate Pharmacometric Model to Define the Impact of Second-Line Immunotherapies on the Survival Outcome of the IMpower131 Study.

Krishnan SM, Friberg LE, Mercier F, Zhang R, Wu B, Jin JY, Hoang T, Ballinger M, Bruno R, Karlsson MO. Krishnan SM, et al. Among authors: wu b. Clin Pharmacol Ther. 2023 Apr;113(4):851-858. doi: 10.1002/cpt.2838. Epub 2023 Jan 29. Clin Pharmacol Ther. 2023. PMID: 36606486

3

Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103).

Garralda E, Oh DY, Italiano A, Bedard PL, Delord JP, Calvo E, LoRusso P, Wainberg Z, Cervantes A, Rodriguez-Vida A, Shemesh CS, Sane R, Mendus D, Ding H, Hendricks R, Meng R, Cho BC, Kim TW, Wu B. Garralda E, et al. Among authors: wu b. J Clin Pharmacol. 2024 May;64(5):544-554. doi: 10.1002/jcph.2397. Epub 2024 Jan 17. J Clin Pharmacol. 2024. PMID: 38105505 Clinical Trial.

4

Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors.

Shemesh CS, Wang Y, An A, Ding H, Chan P, Liu Q, Chen YW, Wu B, Wu Q, Wang X. Shemesh CS, et al. Among authors: wu b, wu q. Cancer Chemother Pharmacol. 2024 Mar 7. doi: 10.1007/s00280-024-04650-y. Online ahead of print. Cancer Chemother Pharmacol. 2024. PMID: 38451273

5

Association Between Tumor Size Kinetics and Survival in Patients With Urothelial Carcinoma Treated With Atezolizumab: Implication for Patient Follow-Up.

Tardivon C, Desmée S, Kerioui M, Bruno R, Wu B, Mentré F, Mercier F, Guedj J. Tardivon C, et al. Among authors: wu b. Clin Pharmacol Ther. 2019 Oct;106(4):810-820. doi: 10.1002/cpt.1450. Epub 2019 Jul 5. Clin Pharmacol Ther. 2019. PMID: 30985002

6

Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition-overall survival modeling framework.

Chan P, Marchand M, Yoshida K, Vadhavkar S, Wang N, Lin A, Wu B, Ballinger M, Sternheim N, Jin JY, Bruno R. Chan P, et al. Among authors: wu b. CPT Pharmacometrics Syst Pharmacol. 2021 Oct;10(10):1171-1182. doi: 10.1002/psp4.12686. Epub 2021 Aug 4. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34270868 Free PMC article.

7

Atezolizumab and Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Pharmacokinetic and Safety Assessments Based on Hepatic Impairment Status and Geographic Region.

Shemesh CS, Chan P, Shao H, Xu DZ, Combs D, Vadhavkar S, Bruno R, Wu B. Shemesh CS, et al. Among authors: wu b. Liver Cancer. 2021 Jun 10;10(5):485-499. doi: 10.1159/000515817. eCollection 2021 Sep. Liver Cancer. 2021. PMID: 34721510 Free PMC article.

8

Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework.

Shemesh CS, Chan P, Marchand M, Gonçalves A, Vadhavkar S, Wu B, Li C, Jin JY, Hack SP, Bruno R. Shemesh CS, et al. Among authors: wu b. Clin Pharmacol Ther. 2023 Sep;114(3):644-651. doi: 10.1002/cpt.2953. Epub 2023 Jun 2. Clin Pharmacol Ther. 2023. PMID: 37212707 Clinical Trial.

9

Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab-Response.

Hamid O, Bruno R, Fasso M, O'Hear C, Wu B. Hamid O, et al. Among authors: wu b. Clin Cancer Res. 2020 May 15;26(10):2436. doi: 10.1158/1078-0432.CCR-20-0298. Clin Cancer Res. 2020. PMID: 32414763 No abstract available.

10

Evaluation of atezolizumab immunogenicity: Clinical pharmacology (part 1).

Wu B, Sternheim N, Agarwal P, Suchomel J, Vadhavkar S, Bruno R, Ballinger M, Bernaards CA, Chan P, Ruppel J, Jin J, Girish S, Joshi A, Quarmby V. Wu B, et al. Clin Transl Sci. 2022 Jan;15(1):130-140. doi: 10.1111/cts.13127. Epub 2021 Aug 25. Clin Transl Sci. 2022. PMID: 34432389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,812 results

Search Page